{"log_id": 3970506352660257183, "direction": 0, "words_result_num": 37, "words_result": [{"probability": {"variance": 0.000208, "average": 0.995377, "min": 0.914688}, "location": {"width": 624, "top": 226, "height": 36, "left": 108}, "words": "据表面积推算,分别相当于人等效剂量的0.015和0.04mg/kg)"}, {"probability": {"variance": 0.005802, "average": 0.969829, "min": 0.69972}, "location": {"width": 935, "top": 268, "height": 39, "left": 112}, "words": "致癌性:大鼠经掺食给予利巴韦林剂量为16-200mg/kg长期研究结果提示,利巴韦林可能透发良"}, {"probability": {"variance": 0.005332, "average": 0.980464, "min": 0.637489}, "location": {"width": 935, "top": 313, "height": 39, "left": 109}, "words": "性乳房、胰管、垂体和肾上腺瘤。小鼠和大鼠的18-24个月的初步致癌试验并非最终结果,但这"}, {"probability": {"variance": 0.002039, "average": 0.98701, "min": 0.734403}, "location": {"width": 932, "top": 360, "height": 38, "left": 112}, "words": "些试验证实,给予利巴韦林剂量分别为20-75和10-40mg/kg,小鼠和大分别出现的血管损伤"}, {"probability": {"variance": 0.000245, "average": 0.995696, "min": 0.927541}, "location": {"width": 453, "top": 410, "height": 33, "left": 113}, "words": "和视黄醛还原酶变性与利巴韦林长期给药有关"}, {"probability": {"variance": 3.3e-05, "average": 0.995733, "min": 0.983503}, "location": {"width": 140, "top": 458, "height": 28, "left": 119}, "words": "【药代动力学】"}, {"probability": {"variance": 0.000289, "average": 0.995987, "min": 0.887958}, "location": {"width": 891, "top": 493, "height": 39, "left": 156}, "words": "国内人体生物利用度研究资料表明,利巴韦林颗粒口服后吸收迅速,在60-90分钟内血药浓"}, {"probability": {"variance": 4e-06, "average": 0.998677, "min": 0.992291}, "location": {"width": 940, "top": 537, "height": 40, "left": 109}, "words": "度可达到峰值。利巴韦林进入体内后,经磷酸化生成具有活性的代谢产物利巴韦林单磷酸。消"}, {"probability": {"variance": 9.4e-05, "average": 0.995317, "min": 0.941638}, "location": {"width": 891, "top": 582, "height": 41, "left": 109}, "words": "除半衰期约为24小时。利巴韦林能滞留于红细胞内。主要由肾脏排泄,仅有少量随粪便排"}, {"probability": {"variance": 0.012275, "average": 0.97016, "min": 0.396687}, "location": {"width": 896, "top": 627, "height": 41, "left": 153}, "words": "据 Physician s Desk Reference(54版)介绍,慢性肝炎患者服用利巴韦林单剂量和多剂"}, {"probability": {"variance": 0.001478, "average": 0.987271, "min": 0.773356}, "location": {"width": 936, "top": 672, "height": 39, "left": 112}, "words": "量的药动性质概括在表1中。口服后利巴韦林吸收迅速而完全。然而由于首过效应,绝对生物利"}, {"probability": {"variance": 0.009979, "average": 0.964846, "min": 0.381163}, "location": {"width": 938, "top": 717, "height": 40, "left": 111}, "words": "用度平均值为64%(44)。在单次服用200-1200mg剂量范围内,利巴韦林的剂量与AUC(从0"}, {"probability": {"variance": 0.013, "average": 0.95828, "min": 0.476059}, "location": {"width": 938, "top": 758, "height": 41, "left": 108}, "words": "时间到最后测试点之间的AUC)之间存在线性关系。但剂量与Cmay之间的关系星曲线性的,单"}, {"probability": {"variance": 0.089163, "average": 0.700129, "min": 0.401528}, "location": {"width": 38, "top": 791, "height": 30, "left": 674}, "words": "<"}, {"probability": {"variance": 0.011458, "average": 0.94504, "min": 0.607694}, "location": {"width": 388, "top": 811, "height": 38, "left": 110}, "words": "剂量在40-600mg以上时趋近于渐近线"}, {"probability": {"variance": 0.00952, "average": 0.96043, "min": 0.476204}, "location": {"width": 891, "top": 851, "height": 42, "left": 144}, "words": "多次口服后,可以观察到在血浆中有6倍的利巴韦林蓄积(以AUC钠为基础连续口服60mg"}, {"probability": {"variance": 0.000253, "average": 0.995086, "min": 0.913724}, "location": {"width": 622, "top": 900, "height": 36, "left": 112}, "words": "每日两次,大约四周可以达到稳态,稳态血浆平均浓度为2200"}, {"probability": {"variance": 0.015816, "average": 0.955746, "min": 0.540527}, "location": {"width": 224, "top": 898, "height": 28, "left": 824}, "words": "g/m1,停药后测量的平"}, {"probability": {"variance": 0.000125, "average": 0.994539, "min": 0.950621}, "location": {"width": 731, "top": 942, "height": 40, "left": 110}, "words": "均半衰期为298(30%)小时,这表明本品可能存在从非血浆部分缓慢消除"}, {"probability": {"variance": 0.007973, "average": 0.980962, "min": 0.380406}, "location": {"width": 936, "top": 986, "height": 40, "left": 112}, "words": "食物对利巴韦林吸收的影响:在单剂量药物研究中,当利巴韦林与高脂肪餐(841千卡热量53.8g"}, {"probability": {"variance": 0.000721, "average": 0.991184, "min": 0.831135}, "location": {"width": 937, "top": 1032, "height": 39, "left": 112}, "words": "脂肪,31.6g蛋白质和57.4g糖类)一同食用时,AUC和Cmax增加70%。尚没有足够的数据来证实"}, {"probability": {"variance": 1.6e-05, "average": 0.997788, "min": 0.980973}, "location": {"width": 859, "top": 1076, "height": 40, "left": 110}, "words": "这些结果的临床相关性。临床药效研究时未进行关于食物消耗方面的说明。(见用法与用量"}, {"probability": {"variance": 2.2e-05, "average": 0.997756, "min": 0.973313}, "location": {"width": 937, "top": 1121, "height": 40, "left": 113}, "words": "抗酸剂对利巴韦林吸收的影响:服用利巴韦林的同时服用一种抗酸剂包含镁、铝和二甲硅油,会"}, {"probability": {"variance": 0.000172, "average": 0.994617, "min": 0.934723}, "location": {"width": 734, "top": 1168, "height": 38, "left": 113}, "words": "导致利巴韦林平均值下降14%。单剂量研究结果临床相关性未知。(见表1)"}, {"probability": {"variance": 1e-05, "average": 0.997524, "min": 0.985936}, "location": {"width": 715, "top": 1213, "height": 39, "left": 146}, "words": "表1慢性肝炎成年患者服用利巴韦林后的平均药代动力学参数(N=12)"}, {"probability": {"variance": 0, "average": 0.999555, "min": 0.999127}, "location": {"width": 47, "top": 1268, "height": 26, "left": 236}, "words": "参数"}, {"probability": {"variance": 1.8e-05, "average": 0.997653, "min": 0.983911}, "location": {"width": 264, "top": 1260, "height": 29, "left": 607}, "words": "利巴韦林剂量(变异系数)"}, {"probability": {"variance": 1.6e-05, "average": 0.997243, "min": 0.987241}, "location": {"width": 134, "top": 1309, "height": 27, "left": 516}, "words": "单剂量600mg"}, {"probability": {"variance": 4e-06, "average": 0.998624, "min": 0.992594}, "location": {"width": 227, "top": 1305, "height": 29, "left": 787}, "words": "多剂量600mg每日两次"}, {"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 48, "top": 1369, "height": 20, "left": 253}, "words": " (hr)"}, {"probability": {"variance": 7.2e-05, "average": 0.991172, "min": 0.973374}, "location": {"width": 88, "top": 1362, "height": 22, "left": 531}, "words": "1.7(46)"}, {"probability": {"variance": 0.005045, "average": 0.913809, "min": 0.843697}, "location": {"width": 60, "top": 1426, "height": 24, "left": 246}, "words": " ng/mi"}, {"probability": {"variance": 1e-05, "average": 0.997009, "min": 0.989929}, "location": {"width": 90, "top": 1420, "height": 22, "left": 532}, "words": "782(37)"}, {"probability": {"variance": 1.2e-05, "average": 0.995308, "min": 0.988518}, "location": {"width": 98, "top": 1418, "height": 22, "left": 847}, "words": "3680(85)"}, {"probability": {"variance": 0.003716, "average": 0.952517, "min": 0.840976}, "location": {"width": 92, "top": 1483, "height": 23, "left": 208}, "words": "T1/2(hr)"}, {"probability": {"variance": 2.4e-05, "average": 0.994652, "min": 0.98556}, "location": {"width": 101, "top": 1478, "height": 24, "left": 529}, "words": "43.6(47)"}, {"probability": {"variance": 2e-06, "average": 0.998277, "min": 0.996047}, "location": {"width": 95, "top": 1475, "height": 23, "left": 849}, "words": "298(30)"}], "language": 3}